Qin, Shukui <br/><br/>
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.  [electronic resource] 

 -  Therapeutic advances in medical oncology  2019 
 - 1758835919889001 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1758-8340 
<br/><br/><label>Standard No.: </label>10.1177/1758835919889001  doi